Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

MeSH terms

• Adenine
• Antimetabolites, Antineoplastic / administration & dosage
• Antimetabolites, Antineoplastic / pharmacokinetics*
• Carcinoma, Non-Small-Cell Lung / drug therapy
• Carcinoma, Non-Small-Cell Lung / metabolism*
• Confounding Factors, Epidemiologic
• Cytidine Deaminase / genetics*
• Cytosine
• Deoxycytidine / administration & dosage
• Deoxycytidine / analogs & derivatives*
• Deoxycytidine / pharmacokinetics
• Gemcitabine
• Humans
• Lung Neoplasms / drug therapy
• Lung Neoplasms / metabolism*
• Polymorphism, Genetic
• Polymorphism, Single Nucleotide*
• Research Design